JN
Jalpaben Niravkumar Vyas
About Jalpaben Niravkumar Vyas
Data last updated:
Jalpaben Niravkumar Vyas is a Director at Amerise Pharmaceuticals Private Limited (since 2018), Additional Director at Stersol Private Limited (since 2026) and Designated Partner at Amuna Pharmaceuticals Llp (since 2020), and holds 1 more current directorship. The companies operate in Pharma. The largest current company by reported revenue is Amerise Pharmaceuticals Private Limited at ₹2.18 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Amerise Pharmaceuticals Private Limited U36900GJ2018PTC104672 | Director | 09 Oct 2018 | 2018 | ₹2.18 Cr (FY 2025) | Active |
 Stersol Private Limited U21000GJ2025PTC168832 | Additional Director | 10 Jan 2026 | 2025 | Active | |
 Amuna Pharmaceuticals Llp AAN-1236 | Designated Partner | 16 Sep 2020 | 2018 | Active | |
| Amerigen Life Sciences Llp AAM-2013 | Designated Partner | 09 Mar 2018 | 2018 | Active |
Board colleagues of Jalpaben Niravkumar Vyas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nirav Nalinkumar Vyas | 07869561 | Amerise Pharmaceuticals Private Limited , Amuna Pharmaceuticals Llp and 1 more | Director |
| Devansh Vimalbhai Shah | 11346041 | Stersol Private Limited | Director |
| Jinkesh Shaileshkumar Shah | 11346040 | Stersol Private Limited | Director |
| Mitul Divyang Panchal | 11346042 | Stersol Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jalpaben Niravkumar Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jalpaben Niravkumar Vyas
Jalpaben Niravkumar Vyas currently holds 4 directorships: Amerise Pharmaceuticals Private Limited (Director, since 09 Oct 2018, revenue ₹2.18 Cr (FY 2025)); Stersol Private Limited (Additional Director, since 10 Jan 2026); Amuna Pharmaceuticals Llp (Designated Partner, since 16 Sep 2020); Amerigen Life Sciences Llp (Designated Partner, since 09 Mar 2018).
Jalpaben Niravkumar Vyas was first appointed on 09 Mar 2018 as Designated Partner at Amerigen Life Sciences Llp. The most recent appointment on record is 10 Jan 2026 at Stersol Private Limited.
The current boards of Jalpaben Niravkumar Vyas's companies include Nirav Nalinkumar Vyas (Amerise Pharmaceuticals Private Limited), Devansh Vimalbhai Shah (Stersol Private Limited), Jinkesh Shaileshkumar Shah (Stersol Private Limited), Mitul Divyang Panchal (Stersol Private Limited).